Macrophage microRNA-146a is a central regulator of the foreign body response to biomaterial implants

Insights

MicroRNA-146a (miR-146a) is key in regulating the foreign body response (FBR) to biomaterials. Targeting macrophage miR-146a can inhibit FBR and improve implant biocompatibility.

Area of Science:

  • Biomaterials Science
  • Immunology
  • Molecular Biology

Background:

  • Host recognition and immune responses to biomaterials can impair implant function.
  • The foreign body response (FBR) is a critical challenge in biomaterial development.
  • Understanding the molecular mechanisms of FBR is essential for improving biomaterial biocompatibility.

Approach:

  • Analysis of microRNA (miR) and mRNA expression in response to implanted biomaterials.
  • Utilized a murine implant model to study FBR.
  • Employed global and cell-specific knockout of miR-146a in macrophages to confirm its regulatory role.

Key Points:

  • miR-146a levels inversely correlate with macrophage accumulation, foreign body giant cell (FBGC) formation, and fibrosis.
  • Macrophage-derived miR-146a is a critical regulator of FBR and FBGC formation.
  • miR-146a influences genes involved in inflammation, fibrosis, and mechanosensing, impacting tissue stiffness and cellular mechanics (F-actin production, traction force).

Conclusions:

  • Macrophage miR-146a is a pivotal regulator of the foreign body response.
  • Modulating macrophage miR-146a offers a targeted strategy to mitigate FBR.
  • Inhibiting miR-146a may enhance the biocompatibility of implanted biomaterials.